$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes

$sfes Overview Financials Valuation SEC Filings Company Website

2015 Q4 Form 10-Q Financial Statement

#000008611515000087 Filed on October 23, 2015

Income Statement

Concept	2015 Q4	2015 Q3	2014 Q3
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$4.000M	$4.000M	$4.200M
YoY Change	-11.11%	-4.76%	-12.5%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$200.0K
YoY Change	100.0%
% of Gross Profit
Operating Expenses	$3.900M	$4.000M	$4.200M
YoY Change	-11.36%	-4.76%	-12.5%
Operating Profit	-$3.958M	-$3.962M	-$4.177M
YoY Change	-11.75%	-5.15%	-13.61%
Interest Expense	-$10.20M	-$8.400M	-$9.600M
YoY Change	-4.67%	-12.5%	-7.69%
% of Operating Profit
Other Income/Expense, Net	-$84.00K	$704.0K	-$246.0K
YoY Change	-209.09%	-386.18%	-94.18%
Pretax Income	-$14.27M	-$11.63M	-$14.01M
YoY Change	-5.58%	-16.98%	-27.92%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$14.27M	-$11.63M	-$14.01M
YoY Change	-5.58%	-16.98%	-27.92%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.69	-$0.56	-$0.68
Diluted Earnings Per Share	-$0.69	-$0.56	-$0.68
COMMON SHARES
Basic Shares Outstanding	20.65M shares	20.92M shares	20.68M shares
Diluted Shares Outstanding		20.92M shares	20.68M shares

Balance Sheet

Concept	2015 Q4	2015 Q3	2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$63.90M	$93.50M	$151.9M
YoY Change	-53.43%	-38.45%	-6.7%
Cash & Equivalents	$32.84M	$63.71M	$116.7M
Short-Term Investments	$31.00M	$29.80M	$35.20M
Other Short-Term Assets	$5.800M	$2.000M	$1.500M
YoY Change	241.18%	33.33%	15.38%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$69.67M	$95.48M	$153.4M
YoY Change	-49.82%	-37.76%	-6.53%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.145M	$1.438M	$95.00K
YoY Change	1643.9%	1413.68%	-40.63%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$151.8M	$144.9M	$142.2M
YoY Change	11.66%	1.92%	27.13%
Other Assets	$1.037M	$1.903M	$2.156M
YoY Change	-50.02%	-11.73%	-23.71%
Total Long-Term Assets	$187.2M	$179.7M	$178.9M
YoY Change	4.21%	0.43%	13.5%
TOTAL ASSETS
Total Short-Term Assets	$69.67M	$95.48M	$153.4M
Total Long-Term Assets	$187.2M	$179.7M	$178.9M
Total Assets	$256.8M	$275.2M	$332.3M
YoY Change	-19.35%	-17.2%	3.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$290.0K	$253.0K	$261.0K
YoY Change	28.32%	-3.07%	-30.21%
Accrued Expenses	$2.789M	$3.644M	$3.335M
YoY Change	19.49%	9.27%	-5.79%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$0.00
YoY Change			-100.0%
Total Short-Term Liabilities	$6.417M	$7.034M	$6.666M
YoY Change	-2.14%	5.52%	-16.0%
LONG-TERM LIABILITIES
Long-Term Debt	$51.70M	$51.40M	$50.30M
YoY Change	2.17%	2.19%	2.24%
Other Long-Term Liabilities	$3.965M	$3.928M	$3.471M
YoY Change	13.06%	13.17%	-8.99%
Total Long-Term Liabilities	$3.965M	$3.928M	$3.471M
YoY Change	13.06%	13.17%	-8.99%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.417M	$7.034M	$6.666M
Total Long-Term Liabilities	$3.965M	$3.928M	$3.471M
Total Liabilities	$61.34M	$62.40M	$60.42M
YoY Change	1.17%	3.28%	-0.9%
SHAREHOLDERS EQUITY
Retained Earnings	-$604.3M	-$590.0M	-$529.6M
YoY Change	10.93%	11.4%	-6.02%
Common Stock	$819.6M	$820.8M	$824.7M
YoY Change	-0.28%	-0.47%	0.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$19.57M	$18.08M	$23.15M
YoY Change	1.18%	-21.9%
Treasury Stock Shares	993.0K shares	877.0K shares	1.103M shares
Shareholders Equity	$195.5M	$212.8M	$271.9M
YoY Change
Total Liabilities & Shareholders Equity	$256.8M	$275.2M	$332.3M
YoY Change	-19.35%	-17.2%	3.28%

Cashflow Statement

Concept	2015 Q4	2015 Q3	2014 Q3
OPERATING ACTIVITIES
Net Income	-$14.27M	-$11.63M	-$14.01M
YoY Change	-5.58%	-16.98%	-27.92%
Depreciation, Depletion And Amortization	$200.0K
YoY Change	100.0%
Cash From Operating Activities	-$3.600M	-$2.900M	-$2.700M
YoY Change	-23.4%	7.41%	-43.75%
INVESTING ACTIVITIES
Capital Expenditures	-$1.500M	-$200.0K	$0.00
YoY Change	1400.0%
Acquisitions
YoY Change
Other Investing Activities	-$22.50M	$7.500M	-$45.20M
YoY Change	3114.29%	-116.59%	-806.25%
Cash From Investing Activities	-$24.00M	$7.400M	-$45.10M
YoY Change	3328.57%	-116.41%	-804.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-3.200M	-1.600M	0.000
YoY Change	-557.14%		-100.0%
NET CHANGE
Cash From Operating Activities	-3.600M	-2.900M	-2.700M
Cash From Investing Activities	-24.00M	7.400M	-45.10M
Cash From Financing Activities	-3.200M	-1.600M	0.000
Net Change In Cash	-30.80M	2.900M	-47.80M
YoY Change	555.32%	-106.07%	-896.67%
FREE CASH FLOW
Cash From Operating Activities	-$3.600M	-$2.900M	-$2.700M
Capital Expenditures	-$1.500M	-$200.0K	$0.00
Free Cash Flow	-$2.100M	-$2.700M	-$2.700M
YoY Change	-54.35%	0.0%	-43.75%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Period End Date DocumentPeriodEndDate	2015-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000086115
CY2015Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20649671	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	SAFEGUARD SCIENTIFICS INC
	dei	Trading Symbol TradingSymbol	SFE
CY2015Q3	sfe	Cash Liabilityfor Performance Based Units CashLiabilityforPerformanceBasedUnits	0	USD
CY2001Q4	sfe	Future Annual Payment To Chairman And Chief Executive Officer FutureAnnualPaymentToChairmanAndChiefExecutiveOfficer	650000	USD
CY2015Q3	sfe	Partner Companies Not Consolidated In Financial Statements PartnerCompaniesNotConsolidatedInFinancialStatements	27	nonconsolidated_partner_company
CY2015Q3	sfe	Sharebased Compensation Arrangementby Sharebased Payment Award Numberof Award Vesting Types SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofAwardVestingTypes	3	vesting_type
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	226000	USD
CY2015Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	253000	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2334000	USD
CY2015Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3644000	USD
CY2014Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	819757000	USD
CY2015Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	818671000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1140000	USD
CY2014Q4	us-gaap	Advances To Affiliate AdvancesToAffiliate	9065000	USD
CY2015Q3	us-gaap	Advances To Affiliate AdvancesToAffiliate	10978000	USD
CY2014Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	176000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1583000	USD
CY2015Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	148000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1140000	USD
CY2014Q4	us-gaap	Assets Assets	318454000	USD
CY2015Q3	us-gaap	Assets Assets	275153000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	138844000	USD
CY2015Q3	us-gaap	Assets Current AssetsCurrent	95479000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	139318000	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	116684000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	111897000	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	63708000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-22634000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-48189000	USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2015Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	83333000	shares
CY2015Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	83333000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21573000	shares
CY2015Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21573000	shares
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	2157000	USD
CY2015Q3	us-gaap	Common Stock Value CommonStockValue	2157000	USD
CY2014Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	50563000	USD
CY2015Q3	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	51441000	USD
CY2014Q4	us-gaap	Cost Method Investments CostMethodInvestments	9138000	USD
CY2015Q3	us-gaap	Cost Method Investments CostMethodInvestments	7074000	USD
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.68
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.47
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.56
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.17
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.68
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.47
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.56
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.17
CY2014Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3997000	USD
CY2015Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3137000	USD
CY2014Q4	us-gaap	Equity Method Investments EquityMethodInvestments	135989000	USD
CY2015Q3	us-gaap	Equity Method Investments EquityMethodInvestments	144936000	USD
CY2014Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4177000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14485000	USD
CY2015Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3962000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13596000	USD
CY2014Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	25263000	USD
CY2015Q3	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	29760000	USD
CY2014Q4	us-gaap	Held To Maturity Securities Noncurrent HeldToMaturitySecuritiesNoncurrent	19365000	USD
CY2015Q3	us-gaap	Held To Maturity Securities Noncurrent HeldToMaturitySecuritiesNoncurrent	10705000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-14006000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	9965000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11628000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-45253000	USD
CY2014Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-8962000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-5329000	USD
CY2015Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-7635000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-30062000	USD
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2014Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	1103000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	3295000	USD
CY2015Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	1133000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	3383000	USD
CY2014Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	482000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1494000	USD
CY2015Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	398000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1487000	USD
CY2014Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	154192000	USD
CY2015Q3	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	162988000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	60627000	USD
CY2015Q3	us-gaap	Liabilities Liabilities	62403000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	318454000	USD
CY2015Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	275153000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6557000	USD
CY2015Q3	us-gaap	Liabilities Current LiabilitiesCurrent	7034000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-24865000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1072000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	17706000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-33031000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15475000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14086000	USD
CY2014Q3	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-14006000	USD
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	9965000	USD
CY2015Q3	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-11628000	USD
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-45253000	USD
CY2014Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	3855000	USD
CY2015Q3	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	2640000	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4177000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-14485000	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3962000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-13596000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2075000	USD
CY2015Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1903000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3507000	USD
CY2015Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3928000	USD
CY2014Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-246000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	31580000	USD
CY2015Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	704000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	301000	USD
	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	9868000	USD
	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	10935000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-5000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	25036000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1748000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	54956000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	52181000	USD
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	44578000	USD
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	23875000	USD
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	11000	USD
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	402000	USD
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.10
CY2015Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.10
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2015Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1684000	USD
CY2015Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2011000	USD
	us-gaap	Proceeds From Collection Of Advance To Affiliate ProceedsFromCollectionOfAdvanceToAffiliate	5509000	USD
	us-gaap	Proceeds From Collection Of Advance To Affiliate ProceedsFromCollectionOfAdvanceToAffiliate	1290000	USD
	us-gaap	Proceeds From Divestiture Of Businesses And Interests In Affiliates ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates	81626000	USD
	us-gaap	Proceeds From Divestiture Of Businesses And Interests In Affiliates ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates	25029000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	612000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	676000	USD
	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	39979000	USD
	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	28043000	USD
CY2014Q3	us-gaap	Profit Loss ProfitLoss	-14006000	USD
	us-gaap	Profit Loss ProfitLoss	9965000	USD
CY2015Q3	us-gaap	Profit Loss ProfitLoss	-11628000	USD
	us-gaap	Profit Loss ProfitLoss	-45253000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	123000	USD
CY2015Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1438000	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	441000	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-544746000	USD
CY2015Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-589999000	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	108000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	676000	USD
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1748000	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	257827000	USD
CY2015Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	212750000	USD
CY2014Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	921000	shares
CY2015Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	877000	shares
CY2014Q4	us-gaap	Treasury Stock Value TreasuryStockValue	19341000	USD
CY2015Q3	us-gaap	Treasury Stock Value TreasuryStockValue	18079000	USD
CY2014Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20678000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21418000	shares
CY2015Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20919000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20892000	shares
CY2014Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20678000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21042000	shares
CY2015Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20919000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20892000	shares

Files In Submission

Name	View Source	Status
0000086115-15-000087-index-headers.html	Edgar Link	pending
0000086115-15-000087-index.html	Edgar Link	pending
0000086115-15-000087.txt	Edgar Link	pending
0000086115-15-000087-xbrl.zip	Edgar Link	pending
ex311.htm	Edgar Link	pending
ex312.htm	Edgar Link	pending
ex321.htm	Edgar Link	pending
exx322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sfe-20150930.xml	Edgar Link	completed
sfe-20150930.xsd	Edgar Link	pending
sfe-20150930_cal.xml	Edgar Link	unprocessable
sfe-20150930_def.xml	Edgar Link	unprocessable
sfe-20150930_lab.xml	Edgar Link	unprocessable
sfe-20150930_pre.xml	Edgar Link	unprocessable
sfe-2015xq3.htm	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes

2015 Q4 Form 10-Q Financial Statement

#000008611515000087 Filed on October 23, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SFES SAFEGUARD SCIENTIFICS INC Stock $sfes

2015 Q4 Form 10-Q Financial Statement

#000008611515000087 Filed on October 23, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes